Long-Term Survival in Patients With Anaplastic Oligodendroglioma Who Received Radiotherapy Plus PCV Chemotherapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors
J. Clin. Oncol 2022 Jun 22;[EPub Ahead of Print], AB Lassman, K Hoang-Xuan, MC Polley, AA Brandes, JG Cairncross, JM Kros, LS Ashby, MJB Taphoorn, L Souhami, WNM Dinjens, NN Laack, MCM Kouwenhoven, KL Fink, PJ French, DR Macdonald, D Lacombe, M Won, T Gorlia, MP Mehta, MJ van den BentFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.